Question

In: Accounting

Statement of Cash Flows Angela's Cleaning Consortium Seymour-Johnson, Inc. Comparative Balance Sheet Income Statement December 31,...

Statement of Cash Flows
Angela's Cleaning Consortium Seymour-Johnson, Inc.
Comparative Balance Sheet Income Statement
December 31, 2020 and 2019 For the Year Ended December 31, 2020
2020 2019 Net sales $ 386,000
ASSETS Cost of goods sold     (212,000)
Current assets Gross profit      174,000
   Cash $    66,500 $    62,000 Operating expenses
   Accounts receivable        95,000      113,000 Salaries and wages expense       (66,000)
   Merchandise inventory      172,000      165,000 Depreciation expense       (25,000)
      Total current assets      333,500      340,000 Other operating expenses       (28,000)
Long-term investments Income from operations        55,000
   Investment in Walking Dead Co.                 -        50,000 Other revenues and gains
Property, buildings, and equipment      507,000      304,000    Interest revenue        15,000
   Less: Accumulated depreciation       (59,500)       (42,000)    Dividend revenue          9,700
Total assets $ 781,000 $ 652,000    Gain on disposal of plant assets        12,000
Liabilities and Stockholders' Equity Other expenses and losses
Current liabilities    Interest expense       (15,000)
      Accounts payable $ 144,000 $ 175,000 Income before income taxes        76,700
      Accrued liabilities        17,000        47,000 Income tax expense       (14,000)
      Total current assets      161,000      222,000 Net Income $    62,700
   Long-term Liabilities
      Notes payable, long-term      160,000        90,000
         Total liabilities      321,000      312,000
Stockholders' equity
   Common stock      370,000      250,000
   Retained earnings      140,000        90,000
   Treasury stock       (50,000)                 -
         Total Stockholders’ Equity      460,000      340,000
Total Liabilities & Stockholders' Equity $ 781,000 $ 652,000
Additional Information:
A.   Sold plant assets with a cost of $75,000 and accumulated depreciation of $7,500,
       yielding a gain of disposal of plant assets of $12,000.
B.   Purchased plant assets by paying cash.
C.   Issued Notes Payable for Cash.
D.   Sold investment in Walking Dead Co at cost (zero gain/loss).
E.   Issued Common Stock for Cash.
F.   Purchased Treasury Stock for Cash.
Requirements:
Prepare, in good form, a Statement of Cash Flows using the indirect method.

Solutions

Expert Solution

Cash flow statement using Indirect Method
For the year ended December 31,2020
Cash flow from Operarting activities
Net Income $62,700.00
Adjustments to Net Income
Depreciation $25,000.00
Gain on disposal of plant assets -$12,000.00
Changes in working capital
Decrease in Accounts Receivables $18,000.00
Increase in Inventory -$7,000.00
Decrease in Accounts Payable -$31,000.00
Decrease in accrued liabilities -$30,000.00 -$37,000.00
Net Cash available from Operating activities $25,700.00
Cash flow from Investing activities
Sale of plant assets $79,500.00
Purchase of plant assets -$278,000.00
Sale of investment in Walking Dead Co $50,000.00
Net cash used for Investing activities -$148,500.00
Cash flow from financing activities
Issue of notes payable $70,000.00
Issue of common stock $120,000.00
Purchase of Treasury stock -$50,000.00
Dividend paid -$12,700.00
Net Cash available from Financing activities $127,300.00
Net cash surplus / (deficit) $4,500.00
Add : Cash balance as on 2019 $62,000.00
Ending Cash balance as on 2020 $66,500.00

Related Solutions

Statement of Cash Flows—Direct Method The comparative balance sheet of Canace Products Inc. for December 31,...
Statement of Cash Flows—Direct Method The comparative balance sheet of Canace Products Inc. for December 31, 20Y6 and 20Y5, is as follows: Dec. 31, 20Y6 Dec. 31, 20Y5 Assets Cash $300,150 $278,240 Accounts receivable (net) 108,730 99,930 Inventories 306,930 295,870 Investments 0 114,630 Land 157,440 0 Equipment 338,660 261,590 Accumulated depreciation-equipment (79,280) (70,540) Total assets $1,132,630 $979,720 Liabilities and Stockholders' Equity Accounts payable $205,010 $193,000 Accrued expenses payable 20,390 25,470 Dividends payable 11,330 8,820 Common stock, $10 par 61,160 48,010...
Statement of Cash Flows—Direct Method The comparative balance sheet of Canace Products Inc. for December 31,...
Statement of Cash Flows—Direct Method The comparative balance sheet of Canace Products Inc. for December 31, 20Y6 and 20Y5, is as follows: Dec. 31, 20Y6 Dec. 31, 20Y5 Assets Cash $303,670 $282,160 Accounts receivable (net) 110,010 101,340 Inventories 310,560 300,040 Investments 0 116,240 Land 159,280 0 Equipment 342,630 265,270 Accumulated depreciation-equipment (80,220) (71,530) Total assets $1,145,930 $993,520 Liabilities and Stockholders' Equity Accounts payable $207,410 $195,720 Accrued expenses payable 20,630 25,830 Dividends payable 11,460 8,940 Common stock, $10 par 61,880 48,680...
Statement of Cash Flows—Indirect Method The comparative balance sheet of Livers Inc. for December 31, 20Y3...
Statement of Cash Flows—Indirect Method The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: Dec. 31, 20Y3 Dec. 31, 20Y2 Assets Cash $300,080 $277,530 Accounts receivable (net) 108,710 99,680 Inventories 306,860 295,120 Investments 0 114,340 Land 157,400 0 Equipment 338,580 260,920 Accumulated depreciation—equipment (79,270) (70,360) Total assets $1,132,360 $977,230 Liabilities and Stockholders' Equity Accounts payable (merchandise creditors) $204,960 $192,510 Accrued expenses payable (operating expenses) 20,380 25,410 Dividends payable 11,320 8,800 Common stock,...
Statement of Cash Flows—Direct Method The comparative balance sheet of Canace Products Inc. for December 31,...
Statement of Cash Flows—Direct Method The comparative balance sheet of Canace Products Inc. for December 31, 20Y6 and 20Y5, is as follows: Dec. 31, 20Y6 Dec. 31, 20Y5 Assets Cash $288,060 $266,410 Accounts receivable (net) 104,350 95,680 Inventories 294,580 283,300 Investments 0 109,760 Land 151,090 0 Equipment 325,010 250,470 Accumulated depreciation (76,090) (67,540) Total assets $1,087,000 $938,080 Liabilities and Stockholders' Equity Accounts payable (merchandise creditors) $196,750 $184,800 Accrued expenses payable (operating expenses) 19,570 24,390 Dividends payable 10,870 8,440 Common stock,...
Statement of Cash Flows—Direct Method The comparative balance sheet of Canace Products Inc. for December 31,...
Statement of Cash Flows—Direct Method The comparative balance sheet of Canace Products Inc. for December 31, 20Y6 and 20Y5, is as follows: Dec. 31, 20Y6 Dec. 31, 20Y5 Assets Cash $311,640 $289,230 Accounts receivable (net) 112,900 103,880 Inventories 318,700 307,560 Investments 0 119,160 Land 163,460 0 Equipment 351,620 271,920 Accumulated depreciation-equipment (82,320) (73,330) Total assets $1,176,000 $1,018,420 Liabilities and Stockholders' Equity Accounts payable $212,860 $200,630 Accrued expenses payable 21,170 26,480 Dividends payable 11,760 9,170 Common stock, $10 par 63,500 49,900...
Statement of Cash Flows—Indirect Method The comparative balance sheet of Livers Inc. for December 31, 20Y3...
Statement of Cash Flows—Indirect Method The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: Dec. 31, 20Y3 Dec. 31, 20Y2 Assets Cash $222,990 $209,100 Accounts receivable (net) 80,780 75,100 Inventories 228,030 222,360 Investments 0 86,140 Land 116,960 0 Equipment 251,600 196,590 Accumulated depreciation—equipment (58,900) (53,010) Total assets $841,460 $736,280 Liabilities and Stockholders' Equity Accounts payable (merchandise creditors) $152,300 $145,050 Accrued expenses payable (operating expenses) 15,150 19,140 Dividends payable 8,410 6,630 Common stock,...
Statement of Cash Flows—Indirect Method The comparative balance sheet of Livers Inc. for December 31, 20Y3...
Statement of Cash Flows—Indirect Method The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: Dec. 31, 20Y3 Dec. 31, 20Y2 Assets Cash $256,050 $240,660 Accounts receivable (net) 92,760 86,430 Inventories 261,850 255,910 Investments 0 99,140 Land 134,310 0 Equipment 288,900 226,250 Accumulated depreciation—equipment (67,640) (61,010) Total assets $966,230 $847,380 Liabilities and Stockholders' Equity Accounts payable (merchandise creditors) $174,890 $166,930 Accrued expenses payable (operating expenses) 17,390 22,030 Dividends payable 9,660 7,630 Common stock,...
Statement of Cash Flows—Indirect Method The comparative balance sheet of Livers Inc. for December 31, 20Y3...
Statement of Cash Flows—Indirect Method The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: Dec. 31, 20Y3 Dec. 31, 20Y2 Assets Cash $292,970 $275,040 Accounts receivable (net) 106,130 98,780 Inventories 299,610 292,480 Investments 0 113,310 Land 153,670 0 Equipment 330,560 258,580 Accumulated depreciation—equipment (77,390) (69,730) Total assets $1,105,550 $968,460 Liabilities and Stockholders' Equity Accounts payable (merchandise creditors) $200,100 $190,790 Accrued expenses payable (operating expenses) 19,900 25,180 Dividends payable 11,060 8,720 Common stock,...
Statement of Cash Flows—Indirect Method The comparative balance sheet of Livers Inc. for December 31, 20Y3...
Statement of Cash Flows—Indirect Method The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: Dec. 31, 20Y3 Dec. 31, 20Y2 Assets Cash $313,010 $292,180 Accounts receivable (net) 113,390 104,940 Inventories 320,110 310,700 Investments 0 120,370 Land 164,180 0 Equipment 353,170 274,690 Accumulated depreciation—equipment (82,680) (74,070) Total assets $1,181,180 $1,028,810 Liabilities and Stockholders' Equity Accounts payable (merchandise creditors) $213,790 $202,680 Accrued expenses payable (operating expenses) 21,260 26,750 Dividends payable 11,810 9,260 Common stock,...
Statement of Cash Flows—Indirect Method The comparative balance sheet of Livers Inc. for December 31, 20Y3...
Statement of Cash Flows—Indirect Method The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: Dec. 31, 20Y3 Dec. 31, 20Y2 Assets Cash $241,460 $226,680 Accounts receivable (net) 87,470 81,410 Inventories 246,920 241,060 Investments 0 93,390 Land 126,650 0 Equipment 272,440 213,110 Accumulated depreciation—equipment (63,780) (57,470) Total assets $911,160 $798,180 Liabilities and Stockholders' Equity Accounts payable (merchandise creditors) $164,920 $157,240 Accrued expenses payable (operating expenses) 16,400 20,750 Dividends payable 9,110 7,180 Common stock,...
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT